Thrombopoietin receptor agonist (TpoRA) kills acute human myeloid leukemia cells

Details for Australian Patent Application No. 2008310894 (hide)

Owner The Trustees of the University of Pennsylvania GlaxoSmithKline LLC

Inventors Kolata, Anna; Erickson-Miller, Connie L.; Gewirtz, Alan M.

Agent Davies Collison Cave

Pub. Number AU-B-2008310894

PCT Pub. Number WO2009/048953

Priority 60/998,126 09.10.07 US

Filing date 8 October 2008

Wipo publication date 16 April 2009

Acceptance publication date 26 July 2012

International Classifications

C07D 209/40 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404

A61K 31/426 - 1,3-Thiazoles

A61K 31/427 - not condensed and containing further heterocyclic rings

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/048953 Priority application(s): WO2009/048953

22 July 2010 Alteration of Name

  The name of the applicant has been altered to The Trustees of the University of Pennsylvania; GlaxoSmithKline LLC

26 July 2012 Application Accepted

  Published as AU-B-2008310894

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008310895-Magnetic anastomosis device having improved delivery

2008310891-Camera multi-mount